These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16511752)

  • 1. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia.
    Steenhoff AP; Shah SS; Ratner AJ; Patil SM; McGowan KL
    Clin Infect Dis; 2006 Apr; 42(7):907-14. PubMed ID: 16511752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
    Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
    Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample.
    Finkelstein JA; Huang SS; Daniel J; Rifas-Shiman SL; Kleinman K; Goldmann D; Pelton SI; DeMaria A; Platt R
    Pediatrics; 2003 Oct; 112(4):862-9. PubMed ID: 14523178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.
    Kyaw MH; Lynfield R; Schaffner W; Craig AS; Hadler J; Reingold A; Thomas AR; Harrison LH; Bennett NM; Farley MM; Facklam RR; Jorgensen JH; Besser J; Zell ER; Schuchat A; Whitney CG;
    N Engl J Med; 2006 Apr; 354(14):1455-63. PubMed ID: 16598044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.
    Dias R; Caniça M
    FEMS Immunol Med Microbiol; 2007 Oct; 51(1):35-42. PubMed ID: 17854472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
    Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
    J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine.
    Mera R; Miller LA; Fritsche TR; Jones RN
    Microb Drug Resist; 2008 Jun; 14(2):101-7. PubMed ID: 18491947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups.
    Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT
    Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.
    Black S; France EK; Isaacman D; Bracken L; Lewis E; Hansen J; Fireman B; Austrian R; Graepel J; Gray S; Klein NP
    Pediatr Infect Dis J; 2007 Sep; 26(9):771-7. PubMed ID: 17721369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Burden of Pneumococcal Meningitis and Bacteremia, Serotype Distribution and Antibiotic Resistance in Healthy Children After Conjugated Pneumococcal Vaccine Implementation: Single Center Experience].
    Özdemir H; Ekin Dağ N; Çakmak Taşkın E; Konca HK; Arga G; Nar Ötgün S; Güriz H; Elhan A; Çiftçi E; İnce E
    Mikrobiyol Bul; 2021 Oct; 55(4):492-506. PubMed ID: 34666651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the introduction of pneumococcal conjugate vaccines on serotype prevalence in Kuwait and Saudi Arabia.
    Mokaddas EM; Shibl AM; Elgouhary A; Elsobky M
    Vaccine; 2018 Oct; 36(43):6442-6448. PubMed ID: 30194003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
    Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.